US Congress Subject | Drug therapy

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
USSB4348Intro
25%
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
[Detail][Text][Discuss]
2022-07-13
Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.
USHB7585Intro
25%
Directs the Department of Health and Human Services (HHS) and others to undertake efforts to reduce health disparities. For example, the bill (1) requires more detailed reporting of demographic and health disparities data, including related to public...
[Detail][Text][Discuss]
2022-06-29
To House Subcommittee on Health
USHB6833Engross
50%
Limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit. Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a pl...
[Detail][Text][Discuss]
2022-05-25
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 389.
USSB4170Intro
25%
A bill to reauthorize programs for mental health, and for other purposes.
[Detail][Text][Discuss]
2022-05-10
To Senate Health, Education, Labor, And Pensions Committee
USHB7468Intro
25%
To direct the Director of National Intelligence to submit to Congress a report on the effects of increased production and consumption of alternative proteins on the long-term national security interests of the United States.
[Detail][Text][Discuss]
2022-04-07
To House Intelligence Committee
USHB7400Intro
25%
To direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
[Detail][Text][Discuss]
2022-04-06
To House Subcommittee on Health
USSB3991Intro
25%
A bill to direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United State...
[Detail][Text][Discuss]
2022-04-05
To Senate Finance Committee
USHB5657Engross
50%
Establishes a new, separate registration process to facilitate medical marijuana research. Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and dis...
[Detail][Text][Discuss]
2022-04-05
Received in the Senate.
USSB3974Intro
25%
Prohibits consideration of certain factors, including vaccination status, in decisions about an individual's access to federally provided monoclonal antibody therapies to treat COVID-19. As a condition of receiving the therapies from the federal gove...
[Detail][Text][Discuss]
2022-03-31
To Senate Health, Education, Labor, And Pensions Committee
USSB253Engross
50%
Establishes a new, separate registration process to facilitate research on marijuana. Specifically, the bill directs the Drug Enforcement Administration (DEA) to follow specified procedures to register (1) practitioners to conduct marijuana research,...
[Detail][Text][Discuss]
2022-03-28
Message on Senate action sent to the House.
USHB7213Intro
25%
Expands Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses. Specifically, the bi...
[Detail][Text][Discuss]
2022-03-25
To House Subcommittee on Health
USHB6009Intro
25%
Automatically terminates the COVID-19 public health emergency declared on January 31, 2020, when the Food and Drug Administration approves a new drug (or authorizes the emergency use of a drug) to treat COVID-19.
[Detail][Text][Discuss]
2022-03-09
Motion to Discharge Committee filed by Mr. Schweikert. Petition No: 117-11. (Discharge petition text with signatures.)
USHB6832Intro
25%
Restricts various presidential and federal authorities related to the acquisition of supplies to combat COVID-19. Specifically, the bill prohibits the President from exercising certain authorities under the Defense Production Act of 1950 to prioritiz...
[Detail][Text][Discuss]
2022-02-28
To House Subcommittee on Health
USSB3700Intro
25%
Limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit. Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a pl...
[Detail][Text][Discuss]
2022-02-17
To Senate Finance Committee
USSB3629Intro
25%
Expands access to substance use disorder treatment by modifying the regulation of opioid treatment programs and narcotic drugs used for treatment, including with respect to a patient's unsupervised use of such drugs. Specifically, the Department of H...
[Detail][Text][Discuss]
2022-02-10
To Senate Health, Education, Labor, And Pensions Committee
USHB6625Intro
25%
Prohibits using race or ethnicity as a factor in decisions about an individual's access to COVID-19 treatments (e.g., monoclonal antibody therapies). Specifically, the Department of Health and Human Services (HHS) may not adopt any policy or guidance...
[Detail][Text][Discuss]
2022-02-08
To House Subcommittee on Health
USHB6584Intro
25%
To direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes.
[Detail][Text][Discuss]
2022-02-04
To House Subcommittee on Health
USSB3498Intro
25%
Establishes programs to support research on endemic fungal diseases and the development of antifungal drugs, with a particular focus on Valley Fever. Endemic fungal diseases are fungal infections that tend to occur in specific geographic areas and af...
[Detail][Text][Discuss]
2022-01-13
To Senate Health, Education, Labor, And Pensions Committee
USSB3489Intro
25%
Directs the National Institutes of Health (NIH) to support research on medical products for virus families and viral pathogens with pandemic potential. Specifically, the NIH must establish or continue a multidisciplinary program for supporting resear...
[Detail][Text][Discuss]
2022-01-12
To Senate Health, Education, Labor, And Pensions Committee
USHB6000Intro
25%
Addresses pandemic preparedness and public health issues, caregiver and patient engagement, drug development, insurance coverage, and biomedical research. The Department of Health and Human Services (HHS) must undertake research and other activities ...
[Detail][Text][Discuss]
2022-01-04
To House Biotechnology, Horticulture, and Research Committee
USSB3440Intro
25%
Restricts various presidential and federal authorities related to the acquisition of supplies to combat COVID-19. Specifically, the bill prohibits the President from exercising certain authorities under the Defense Production Act of 1950 to prioritiz...
[Detail][Text][Discuss]
2022-01-04
To Senate Banking, Housing, And Urban Affairs Committee
USSB1605PassAuthorizes Department of Defense (DOD) activities and programs for FY2022 and addresses various other issues. For example, the bill provides or extends procurement authority for certain helicopters and amphibious shipbuilding programs; imposes variou...
[Detail][Text][Discuss]
2021-12-27
Became Public Law No: 117-81.
USHB3537PassEstablishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award ...
[Detail][Text][Discuss]
2021-12-23
Became Public Law No: 117-79.
USHB6279Intro
25%
Expands access to substance use disorder treatment by modifying the regulation of opioid treatment programs and narcotic drugs used for treatment, including with respect to a patient's unsupervised use of such drugs. Specifically, the Department of H...
[Detail][Text][Discuss]
2021-12-15
To House Subcommittee on Health
USSB3386Intro
25%
Authorizes actions, including the provision of international assistance, to combat tuberculosis. The President may provide international assistance for the prevention, treatment, control, and elimination of tuberculosis. The President must also estab...
[Detail][Text][Discuss]
2021-12-14
To Senate Foreign Relations Committee
USSB3291Intro
25%
Expands various initiatives to address antibiotic resistance. The bill reestablishes the interagency Antimicrobial Resistance Task Force to coordinate and develop efforts addressing antibiotic resistance. The Department of Health and Human Services m...
[Detail][Text][Discuss]
2021-12-01
To Senate Health, Education, Labor, And Pensions Committee
USSR461Intro
25%
This resolution supports (1) the goals and ideals of World AIDS Day, including the goal to achieve zero new HIV infections, zero discrimination, and zero AIDS-related deaths; (2) efforts to end the HIV epidemic in the United States and around the wor...
[Detail][Text][Discuss]
2021-11-30
To Senate Foreign Relations Committee
USHR813Intro
25%
This resolution encourages people around the world to work to achieve the goal of zero new HIV transmissions, zero discrimination, and zero AIDS-related deaths, in order to end the HIV epidemic in the United States and around the world by 2030. The r...
[Detail][Text][Discuss]
2021-11-19
To House Subcommittee on Health
USHB4035Engross
50%
Expands data collection on the effectiveness of veteran treatment court programs, incentivizes local governments to improve retention rates in veteran treatment court programs and drug court programs, and expands options for veterans to participate i...
[Detail][Text][Discuss]
2021-10-28
To Senate Judiciary Committee
USHB5699Intro
25%
Expands the types of medical personnel authorized to administer or use a covered countermeasure (i.e., a qualified pandemic or epidemic product, a security countermeasure, certain drugs, biomedical products, or medical devices, or a respiratory prote...
[Detail][Text][Discuss]
2021-10-25
To House Subcommittee on Health
USHB5663Intro
25%
Prohibits the Department of Health and Human Services (HHS) from implementing any policy that restricts health care facilities from ordering and receiving COVID-19 monoclonal antibody therapies directly from manufacturers and distributors. In additio...
[Detail][Text][Discuss]
2021-10-22
To House Subcommittee on Health
USHB2379Engross
50%
Reauthorizes through FY2027 and otherwise changes the State Opioid Response Grant program. This program, which is managed by the Substance Abuse and Mental Health Services Administration, provides funding for states, territories, and Indian tribes an...
[Detail][Text][Discuss]
2021-10-21
To Senate Health, Education, Labor, And Pensions Committee
USSB1779Intro
25%
Eliminates veterans' copayments for medication, hospital care, and medical services related to preventive health services provided by the Department of Veterans Affairs. The bill expands the definition of preventive health services to include (1) evi...
[Detail][Text][Discuss]
2021-10-20
Committee on Veterans' Affairs. Hearings held.
USHB19Intro
25%
Establishes and modifies several programs and requirements to address prescription drug prices. The bill modifies provisions under Medicare and Medicaid relating to prescription drug coverage and price transparency. Among other changes, the bill requ...
[Detail][Text][Discuss]
2021-10-19
To House Subcommittee on Antitrust, Commercial, and Administrative Law
USHB2366Intro
25%
Addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances. Specifically, the bill expands surveillance of fentanyl and relate...
[Detail][Text][Discuss]
2021-10-19
To House Subcommittee on Crime, Terrorism, and Homeland Security
USHB5566Intro
25%
Establishes programs to support research on endemic fungal diseases and the development of antifungal drugs, with a particular focus on Valley Fever. Endemic fungal diseases are fungal infections that tend to occur in specific geographic areas and af...
[Detail][Text][Discuss]
2021-10-13
To House Subcommittee on Health
USHB5435Intro
25%
Requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence. The center must develop and implement processes to coordinate FDA activities related to a major disease area or areas affecting the brain or central n...
[Detail][Text][Discuss]
2021-10-01
To House Subcommittee on Health
USHB1456Intro
25%
Reauthorizes through FY2025 and modifies operations of the Peace Corps. Changes include expanding benefits and services for volunteers by increasing the readjustment allowance paid to volunteers when their service terminates and providing statutory a...
[Detail][Text][Discuss]
2021-09-30
Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
USSB2901Intro
25%
Tasks the Substance Abuse and Mental Health Services Administration (SAMHSA) with various activities to promote the availability of high-quality recovery housing for individuals with substance use disorders. Recovery housing refers to shared living e...
[Detail][Text][Discuss]
2021-09-29
To Senate Health, Education, Labor, And Pensions Committee
USSB2866Intro
25%
Prohibits the Department of Health and Human Services (HHS) from implementing any policy that restricts health care facilities from ordering and receiving COVID-19 monoclonal antibody therapies directly from manufacturers and distributors. In additio...
[Detail][Text][Discuss]
2021-09-28
To Senate Health, Education, Labor, And Pensions Committee
USHB5260Intro
25%
Establishes and alters several programs and requirements relating to the prices of prescription drugs. For example, the bill establishes and alters several requirements under Medicare and Medicaid, including requiring drug manufacturers to issue reba...
[Detail][Text][Discuss]
2021-09-15
To House Subcommittee on Health
USHB5237Intro
25%
Establishes and alters several programs and requirements relating to the prices of prescription drugs. For example, the bill establishes and alters several requirements under Medicare and Medicaid, including requiring drug manufacturers to issue reba...
[Detail][Text][Discuss]
2021-09-13
To House Subcommittee on Health
USHB5003Intro
25%
Addresses issues related to the manufacture of drugs, including essential medicines. The Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs must jointly develop and implement a strategy to incre...
[Detail][Text][Discuss]
2021-09-09
To House Subcommittee on Oversight and Investigations
USHR589Intro
25%
This resolution expresses the sense of the House of Representatives that policies concerning medication abortions should be grounded in science, be based on a review of medical evidence, and ensure equitable access for patients.
[Detail][Text][Discuss]
2021-08-18
To House Subcommittee on Health
USSB2622Intro
25%
Provides for Medicaid and Children's Health Insurance Program (CHIP) coverage of certain tobacco cessation services. Specifically, the bill provides for coverage, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacothera...
[Detail][Text][Discuss]
2021-08-05
To Senate Finance Committee
USSB2640Intro
25%
Establishes a program to develop vaccines, diagnostics, and other medical countermeasures for unknown viral threats. Specifically, the Biomedical Advanced Research and Development Authority must carry out the program in consultation with the Public H...
[Detail][Text][Discuss]
2021-08-05
To Senate Health, Education, Labor, And Pensions Committee
USSR336Intro
25%
This resolution designates September 15, 2021, as International Myotonic Dystrophy Awareness Day. Myotonic dystrophy is an inherited disorder characterized by progressive muscle loss and weakness.
[Detail][Text][Discuss]
2021-08-04
To Senate Judiciary Committee
USSB1046Engross
50%
Revises and reauthorizes through FY2026 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with sub...
[Detail][Text][Discuss]
2021-08-03
Held at the desk.
USHB3932Intro
25%
Authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $11 billion in appropriations for activities under the bill, and contains other related provisions. A ma...
[Detail][Text][Discuss]
2021-08-02
To House Subcommittee on Health
USSB2529Intro
25%
Allows certain C corporation taxpayers to elect an increased advance refund of net operating loss carryovers attributable to COVID-19 research expenditures in 2020 and 2021. The bill also allows such taxpayers an advance refund of certain other net o...
[Detail][Text][Discuss]
2021-07-29
To Senate Finance Committee
Syndicate content
feedback